Ellevest, Inc. Jazz Pharmaceuticals PLC Transaction History

Ellevest, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$133.98 - $160.47 $15,139 - $18,133	113 Added 251.11%	158 $23,000
Q4 2022 Feb 03, 2023	BUY	$129.72 - $159.85 $389 - $479	3 Added 7.14%	45 $7,000
Q3 2022 Nov 02, 2022	BUY	$126.59 - $161.18 $3,164 - $4,029	25 Added 147.06%	42 $6,000
Q4 2021 Jan 24, 2022	SELL	$119.87 - $145.67 $6,952 - $8,448	-58 Reduced 77.33%	17 $2,000
Q3 2021 Oct 19, 2021	BUY	$128.64 - $184.79 $9,647 - $13,859	75 New	75 $10,000
Q2 2021 Jul 13, 2021	SELL	$160.2 - $186.42 $14,738 - $17,150	-92 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$150.19 - $173.5 $1,952 - $2,255	13 Added 16.46%	92 $15,000
Q4 2020 Feb 04, 2021	BUY	$140.71 - $165.05 $7,035 - $8,252	50 Added 172.41%	79 $13,000
Q3 2020 Oct 26, 2020	BUY	$105.46 - $144.13 $3,058 - $4,179	29 New	29 $4,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.